Figure 1.
Survival rate of 15 month old mice during the course of the experiment for the two treatments.
Empty dots: anti-IL-10R/PBS; full dots: anti-IL-10R/LPS; empty triangles: IgG/PBS; full triangles: IgG/LPS. None of the 3 month old mice died during the course of the experiment.
Table 1.
Log-linear model reporting the effect of the experimental treatments and body mass variation (percent variation in body mass between day 0 and day 2) on the survival rate of 15 months old mice.
Figure 2.
Temporal change in body mass of mice treated with anti-IL-10R antibodies or IgG.
(A) LPS; (B) PBS. The bars represent the mean ± SE.
Table 2.
Generalized linear mixed model reporting the effect of the experimental treatments and age on the temporal variation in body mass (day 0, 2, 8).
Figure 3.
Changes in body mass of mice treated with anti-IL-10R antibodies or IgG.
(A) young individuals; (B) old individuals. The bars represent the mean ± SE.
Figure 4.
Effect of the anti-IL-10R treatment on the production of plasmatic serum amyloid A.
The bars represent the mean ± SE.
Figure 5.
Effect of the LPS treatment on the production of plasmatic serum amyloid A.
The bars represent the mean ± SE.
Table 3.
Generalized linear mixed model reporting the effect of the experimental treatments and age on the temporal variation (day 0, and 8) in the plasma concentration of the serum amyloid A.